Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis.
about
The Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical EvidencePerioperative management of patient with intracoronary stent presenting for noncardiac surgeryCan Platforms Affect the Safety and Efficacy of Drug-Eluting Stents in the Era of Biodegradable Polymers?: A Meta-Analysis of 34,850 Randomized IndividualsA selective microRNA-based strategy inhibits restenosis while preserving endothelial function.Two-Year Safety and Efficacy of Biodegradable Polymer Drug-Eluting Stent Versus Second-Generation Durable Polymer Drug-Eluting Stent in Patients With Acute Myocardial Infarction: Data from the Korea Acute Myocardial Infarction Registry (KAMIR).Harmonizing Optimal Strategy for Treatment of coronary artery diseases--comparison of REDUCtion of prasugrEl dose or POLYmer TECHnology in ACS patients (HOST-REDUCE-POLYTECH-ACS RCT): study protocol for a randomized controlled trial.Vascular response to bioresorbable polymer sirolimus-eluting stent vs. permanent polymer everolimus-eluting stent at 9-month follow-up: an optical coherence tomography sub-study from the CENTURY II trialBiodegradable Metals for Cardiovascular Stents: from Clinical Concerns to Recent Zn-Alloys.Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent for Percutaneous Coronary Revascularization: 2-Year Results of the BIOSCIENCE TrialTreatment for in-stent restenosis: patient-specific decision rather than universal recommendationThree-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials.Stenting of coronary bifurcation lesions: a literature and technical review.Clinical outcomes of biodegradable polymer biolimus-eluting BioMatrix stents versus durable polymer everolimus-eluting Xience stents.Adverse cardiovascular events associated with biodegradable polymer drug-eluting stents and durable polymer everolimus-eluting stents: A systematic review and meta-analysis of 10 randomized controlled trials.Comparison between imported versus domestic drug-eluting stents in China: A large single-center data.Effect of biodegradable polymer drug-eluting stents versus biocompatible polymer everolimus-eluting stents: a meta-analysis.Drug-eluting balloon versus bare-mental stent and drug-eluting stent for de novo coronary artery disease: A systematic review and meta-analysis of 14 randomized controlled trials.Surface treatments for controlling corrosion rate of biodegradable Mg and Mg-based alloy implants.Outcomes of Acute Myocardial Infarction Patients Implanted With Biodegradable Polymer Biolimus-Eluting Stents Versus New-Generation Durable Polymer Drug-Eluting Stents: A Retrospective Analysis.Five-year clinical performance of a biodegradable polymer-coated biolimus-eluting stent in unselected patients.Safety and efficacy profile of bioresorbable-polylactide-polymer-biolimus-A9-eluting stents versus durable-polymer-everolimus- and zotarolimus-eluting stents in patients with acute coronary syndrome.Comparison of 4.5-Year Outcomes of Bare-Metal and Zotarolimus-Eluting Stents in New York.Long Coronary Lesions Treated With Thin Strut Bioresorbable Polymer Drug Eluting Stent: Experience From Multicentre Randomized CENTURY II Study.Comparison of the Absorbable Polymer Sirolimus-Eluting Stent (MiStent) to the Durable Polymer Everolimus-Eluting Stent (Xience) (from the DESSOLVE I/II and ISAR-TEST-4 Studies).Experimental and computational study of mechanical and transport properties of a polymer coating for drug-eluting stents.Metallic Limus-Eluting Stents Abluminally Coated with Biodegradable Polymers: Angiographic and Clinical Comparison of a Novel Ultra-Thin Sirolimus Stent Versus Biolimus Stent in the DESTINY Randomized Trial.Prolonged dual antiplatelet therapy after drug-eluting stenting: meta-analysis of randomized trials.A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the treatment of female patients with de novo coronary artery lesions: The SPIRIT WOMEN study.Ionic Driven Embedment of Hyaluronic Acid Coated Liposomes in Polyelectrolyte Multilayer Films for Local Therapeutic Delivery.Contemporary drug-eluting stents and companion polymers: durable is not synonymous with harm.Biological effect of microengineered grooved stents on strut healing: a randomised OCT-based comparative study in humans.The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model of restenosis.Comparison of the safety and efficacy of biodegradable polymer biolimus-eluting stents and durable polymer everolimus-eluting stents: propensity score-matched analysis.One-year outcome from an all-comers population of patients with ST-segment elevation myocardial infarction treated with biolimus-eluting stent with biodegradable polymer.TIOMAX: A Spanish Multicenter Registry of the real-world use of the TItanium OptiMAX(®) biostent: TIOMAX: Registro Español Multicéntrico Del Biostent De Titanio OptiMAX(®) En La Vida Real.Percutaneous coronary intervention or coronary artery bypass grafting for unprotected left main coronary artery disease.Randomized comparison of novel biodegradable polymer and durable polymer-coated cobalt-chromium sirolimus-eluting stents: Three-Year Outcomes of the I-LOVE-IT 2 Trial.Bioresorbable Vascular Scaffold Implantation for Successful Treatment of a Symptomatic Coronary Lesion in a 17-Year-Old Boy After Kawasaki Disease.Rationale and study design of the RESERVOIR trial: a randomized trial comparing reservoir-based polymer-free amphilimus-eluting stents versus everolimus-eluting stents with durable polymer in patients with diabetes mellitus.Drug-eluting balloons with provisional bail-out or adjunctive stenting in de novo coronary artery lesions-a systematic review and meta-analysis.
P2860
Q28067509-DC75701D-CC62-41D2-B0B6-ED3ABEBB4212Q28075834-C22DE6D1-6830-4AAA-8F52-72E43D64FB78Q28551120-24E4DCF6-F1F8-45C5-86E3-1BB73EF74E17Q34129012-C48DB0A5-FB8A-4884-A6F9-CFE1D43E573FQ35974060-2DDB5CD5-DA91-47B0-9624-20F30DF25992Q36060147-EAD64570-84E9-43BC-B69E-E7C76810BE2CQ36384518-5F090F2D-6484-4E0C-AEF4-928038585BACQ36996193-365C4491-B3FB-4766-94C4-302007E08F10Q37090890-FE6BA447-9A00-4E1A-8C34-8D4E1564184EQ37208755-B59E58B3-1A9F-4BD9-A1B0-81E619BE5E34Q38398230-5CC0A2FD-F77D-4EFC-8E21-DF9385914236Q38451897-74FD8DB3-4A01-4373-993A-9F2C3B4A14C1Q38630250-12EC3564-0944-41EB-8D72-1B7EC9EB167CQ38682427-C52C39F9-9445-4009-AC3C-A78822F98866Q38697308-56C7D141-9E6A-48E6-AECD-788BE0E5E7B6Q38734700-2637532B-5DA9-4E4F-88F0-BB7876A5D004Q38818530-8A957CE5-7C36-4BB4-B8C4-6441FA8D43EDQ38967006-FCD8C52C-B28E-402D-99F1-6046111D7A02Q39166453-AF3403A5-0AD7-4DBC-84CC-DDEBD47AA1E6Q39502082-A6A826B0-F15D-42F7-80A2-DF733331ABA1Q39632788-835B07BF-8A62-4247-B9A7-9CC3FBCB1514Q39722125-E53A4B52-6371-40F7-A63E-802F20B923D1Q40006460-D77AB2A6-E403-4E08-865F-6660DCE8E4A4Q40112459-745B20F2-0962-4191-9094-505CFA690847Q40273207-DB7837A2-27BB-4C77-9DFE-4977B4214B6AQ40559009-333B7376-49E8-4366-993C-8F224A6F573BQ41028031-7F5D4DB1-4A21-4843-BAEA-3F3D75F785B6Q41347740-2A18B811-1418-42FD-B945-F008BB7BFCF1Q41543808-66F8ED11-3710-4D59-961B-7842AA220468Q42120824-80747E07-7642-4D4C-B0A3-9AB9E27F5A7EQ42201387-6713F709-0351-417E-8410-E9940619292CQ42284707-9FA5C001-DEF5-4C0E-A17B-0267D1B7150AQ45690043-B8BBE62C-71C2-4457-9B64-C032F21D02BCQ46002346-580EF3FB-4A59-4B63-8768-817FE5DD2134Q47616301-735AB0E0-125A-494C-99BC-01D789F21FE8Q48122593-DCFD3CBC-2729-45E6-85A8-9822AAA906DCQ50096658-37EFD5CC-64DB-4B02-9BF9-3DEDB2304643Q53211353-DD564851-09F7-43D3-A1EE-BDC3B2CE0F38Q53395463-58E0FB6A-DD98-4FA2-88F3-0BB45558BE28Q55245991-02372926-D8DC-4850-B8E7-D450C1E360B1
P2860
Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Biodegradable-polymer drug-elu ...... pproach network meta-analysis.
@en
type
label
Biodegradable-polymer drug-elu ...... pproach network meta-analysis.
@en
prefLabel
Biodegradable-polymer drug-elu ...... pproach network meta-analysis.
@en
P2093
P50
P356
P1476
Biodegradable-polymer drug-elu ...... pproach network meta-analysis.
@en
P2093
Bon-Kwon Koo
David E Kandzari
David J Cohen
Do-Yoon Kang
Hyo-Soo Kim
Hyun-Jae Kang
Kyung Taek Park
Kyung Woo Park
Seung-Sik Hwang
Si-Hyuck Kang
P304
P356
10.1093/EURHEARTJ/EHT570
P577
2014-01-23T00:00:00Z